Families looking for ways to manage autism spectrum disorder (ASD) often look toward medications that affect GABA, a chemical in the brain. A recent review looked at three specific drugs: bumetanide, arbaclofen, and valproate. These are all used to target different aspects of how the brain processes information.
The study found some initial signs of improvement in overall autism severity and adaptive behavior. However, when researchers applied a stricter statistical test to account for multiple comparisons, those improvements were no longer considered significant. Other areas, like social communication and repetitive behaviors, did not show any clear changes at all.
Because the evidence is currently weak to moderate, these findings are mostly used to help scientists form new ideas rather than as a confirmed treatment plan. The drugs also caused some side effects related to digestion, nerves, and appetite. Because of these mixed results and the limited certainty of the data, it is important for families to talk with their doctors before making any changes.
